A Pilot Study on the Dual Role of ADAMTS-1, -4, and -5 in Necrotizing Enterocolitis: Linking Tissue Pathology and Serum Biomarker Discovery
- 26 September 2025
- journal article
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 43 (07) , 882-894
Abstract
Necrotizing enterocolitis (NEC) is an inflammatory and destructive disease of the gastrointestinal system, predominantly affecting premature infants. Despite being associated with multifactorial causes, its etiopathogenesis has not yet been clearly elucidated. This study aims to investigate the role of matrix metalloproteinases, particularly the thrombospondin motif-containing proteins ADAMTS-1, -4, and -5, in the pathogenesis of NEC. Intestinal tissue samples were obtained from 31 patients incluiding preterm infants with surgically confirmed NEC. The mRNA expression levels of ADAMTS-1, -4, and -5 were analyzed using RT-qPCR. In addition, immunohistochemical analyses were performed to evaluate the expression of ADAMTS-1, -4, and -5 proteins in tissue samples. Serum levels of these proteins were measured using the ELISA method. RT-qPCR analyses revealed significantly higher expression levels of ADAMTS-1, -4, and -5 in NEC tissue samples compared with the control tissue samples (p < 0.05). Immunohistochemical analysis demonstrated increased expression patterns of these proteins in the NEC group relative to controls (p < 0.05). Furthermore, serum levels of ADAMTS-1, -4, and -5 were found to be elevated in NEC patients (p < 0.05). ROC analysis revealed excellent diagnostic performance of ADAMTS proteins, particularly for ADAMTS-4 (AUC: 1.00), indicating their potential as a non-invasive biomarker for NEC. ADAMTS levels significantly correlated with CRP and IL-6, supporting their involvement in the inflammatory cascade of NEC. The observed upregulation of ADAMTS-1, -4, and -5 in NEC-affected tissues and serum may provide new insights into the disease's pathogenesis and diagnosis. ADAMTS proteins may serve as novel diagnostic biomarkers and therapeutic targets for early identification and treatment of NEC. Targeting members of the ADAMTS protein family could represent a promising therapeutic strategy for the treatment of NEC.Keywords
This publication has 33 references indexed in Scilit:
- The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a reviewOncogene, 2022
- ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease2022
- Extracellular matrix requirements for gastrointestinal organoid culturesBiomaterials, 2021
- Regulation of ADAMTS-1, -4 and -5 expression in human macrophages: Differential regulation by key cytokines implicated in atherosclerosis and novel synergism between TL1A and IL-17Cytokine, 2013
- Proteases involved in cartilage matrix degradation in osteoarthritisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012
- Proteoglycan degradation by the ADAMTS family of proteinasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- The NFKB1 (g.-24519delATTG) Variant is Associated with Necrotizing Enterocolitis (NEC) in Premature InfantsJournal of Surgical Research, 2011
- Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degenerationArthritis & Rheumatism, 2009
- Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS‐4 and ADAMTS‐5Arthritis & Rheumatism, 2007
- Necrotizing Enterocolitis: Treatment Based on Staging CriteriaPediatric Clinics of North America, 1986